Casey Kilborne
Primary Care · Utica, NYNPI 1225656648
Payments from drug & device makers
Across 58 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$350
- Grifols USA, LLC$141
- AstraZeneca$73
- Pfizer$56
- Baxter Healthcare$38
- Jazz Pharmaceuticals Inc.$34
- plus $388 from 16 others
What the payments were for
- Food & beverage$98091%
- Education$1009%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 13 | $350 |
| Grifols USA, LLC | 12 | $141 |
| AstraZeneca | 5 | $73 |
| Pfizer | 3 | $56 |
| Baxter Healthcare | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| GSK | 2 | $32 |
| Boehringer Ingelheim | 2 | $32 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Novo Nordisk | 2 | $30 |
| Merck | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| Organon | 1 | $23 |
| AbbVie | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Convatec Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Amgen | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,080 in reported general payments places this provider in the 70th percentile of 239 primary care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 11 | $571 |
Paid to pharmacies, not to this prescriber.
Other primary care in Utica
- Dorothy KleinertNew York$27K
- Stephanie KhanForest Hills$16K
- Albert MarcanoJackson Heights$15K
- Elizabeth GattmanJamestown$10K
- Vanessa WangFlushing$10K
- Elizabeth SmithWaterloo$9K
- Eric RodriguezSyracuse$7K
- Natalie Sommerville-BrooksBrooklyn$6K
- Lisa PlanetaNew York$6K
- Pao-Ju TsengFlushing$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.